Literature DB >> 15205722

An evaluation of the United Kingdom National Osteoporosis Society position statement on the use of peripheral dual-energy X-ray absorptiometry.

Rajesh Patel1, Glen M Blake, Ignac Fogelman.   

Abstract

A recent position statement issued by the UK National Osteoporosis Society recommends a triage approach to the use of peripheral dual-energy X-ray absorptiometry (pDXA) devices. Patients with a forearm T-score greater than -1 or less than -2.5 are regarded as normal or osteoporotic, respectively, while those with a T-score between -1 and -2.5 are sent for further assessment with spine and hip DXA. We have evaluated the NOS pDXA algorithm by comparing it with the alternative strategies of relying on forearm BMD alone, or performing spine and hip DXA in every patient. The evaluation was carried out using a mathematical model, and the predictions were compared with in vivo data obtained in patients referred for investigation by their general practitioner. In the model the population distribution of spine, hip, and forearm BMD was described by a trivariant Gaussian function. Relative risks of fracture were taken from a meta-analysis. The three strategies were compared using receiver operating characteristic (ROC) curves in which the percentage of future fracture cases identified was plotted against the percentage of the whole population found to have osteoporosis. ROC curves plotted for the discrimination of hip, vertebral, and Colles fracture risk and the risk of a fracture at any skeletal site were similar for all three strategies, with the curves for the NOS pDXA algorithm nearly identical to those for spine and hip DXA. For the case of hip fracture, vertebral fracture, or a fracture at any site, forearm BMD was slightly inferior to the NOS algorithm, but the reverse was true for Colles fracture. The small difference between the ROC curves suggests that forearm BMD used alone can reproduce clinical decision-making with the NOS pDXA algorithm provided that a T-score threshold of T=-2.1 is used for the diagnosis of osteoporosis, instead of the conventional figure of T=-2.5. Results from the in vivo study were in good agreement with the predictions of the model, although some differences were observed that were explained by inaccuracies in the forearm reference data. We conclude that use of forearm BMD alone with a modified T-score threshold of -2.1 would save the need for spine and hip DXA scans and identify only slightly fewer fracture cases for treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15205722     DOI: 10.1007/s00198-003-1565-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  31 in total

1.  Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment.

Authors:  Paul D Miller; Ethel S Siris; Elizabeth Barrett-Connor; Kenneth G Faulkner; Lois E Wehren; Thomas A Abbott; Ya-Ting Chen; Marc L Berger; Arthur C Santora; Louis M Sherwood
Journal:  J Bone Miner Res       Date:  2002-12       Impact factor: 6.741

2.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Delmas; P Burckhardt; C Cooper; D Torgerson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women.

Authors:  M L Bouxsein; R A Parker; S L Greenspan
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

4.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

5.  Classification of osteoporosis based on bone mineral densities.

Authors:  Y Lu; H K Genant; J Shepherd; S Zhao; A Mathur; T P Fuerst; S R Cummings
Journal:  J Bone Miner Res       Date:  2001-05       Impact factor: 6.741

Review 6.  Quantitative bone mineral assessment at the forearm: a review.

Authors:  P Augat; T Fuerst; H K Genant
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

7.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

8.  Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial.

Authors:  Pierre D Delmas; Kristine E Ensrud; Jonathan D Adachi; Kristine D Harper; Somnath Sarkar; Carlo Gennari; Jean-Yves Reginster; Huibert A P Pols; Robert R Recker; Steven T Harris; Wentao Wu; Harry K Genant; Dennis M Black; Richard Eastell
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

9.  A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.

Authors:  Jean-Jacques Body; Gregory A Gaich; Wim H Scheele; Pandurang M Kulkarni; Paul D Miller; Anne Peretz; Robin K Dore; Ricardo Correa-Rotter; Alexandra Papaioannou; David C Cumming; Anthony B Hodsman
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

Review 10.  Peripheral or central densitometry: does it matter which technique we use?

Authors:  G M Blake; I Fogelman
Journal:  J Clin Densitom       Date:  2001       Impact factor: 2.963

View more
  4 in total

1.  Comparison of bone mineral density in the jaws of patients with and without chronic periodontitis.

Authors:  M Oztürk Tonguç; U S Büyükkaplan; O Fentoglu; B A Gümüs; S S Çerçi; F Y Kirzioglu
Journal:  Dentomaxillofac Radiol       Date:  2012-01-12       Impact factor: 2.419

2.  Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice.

Authors:  J A Clowes; N F A Peel; R Eastell
Journal:  Osteoporos Int       Date:  2006-06-30       Impact factor: 4.507

3.  Use of clinical risk factors to identify postmenopausal women with vertebral fractures.

Authors:  J H Tobias; A P Hutchinson; L P Hunt; E V McCloskey; M D Stone; J C Martin; P W Thompson; T G Palferman; A K Bhalla
Journal:  Osteoporos Int       Date:  2006-09-02       Impact factor: 4.507

4.  A list of device-specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations.

Authors:  G M Blake; D J Chinn; S A Steel; R Patel; E Panayiotou; J Thorpe; J N Fordham
Journal:  Osteoporos Int       Date:  2005-10-15       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.